IPCALAB.NS

Ipca Laboratories Limited [IPCALAB.NS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

IPCALAB.NS Stock Summary

Top IPCALAB.NS Correlated Resources

IPCALAB.NS


Top 10 Correlated ETFs

IPCALAB.NS


Top 10 Correlated Stocks

IPCALAB.NS


In the News

IPCALAB.NS Financial details

Company Rating
Buy
Market Cap
198.62B
Income
5.25B
Revenue
60.22B
Book val./share
-
Cash/share
-
Dividend
4
Dividend %
0.51%
Employees
15.16K
Optionable
No
Shortable
Yes
Earnings
16 Feb 2023
P/E
37.87
Forward P/E
6.37
PEG
-7.01
P/S
3.3
P/B
3.44
P/C
-
P/FCF
-
Quick Ratio
1.05
Current Ratio
3.29
Debt / Equity
-
LT Debt / Equity
0.08
-
-
EPS (TTM)
20.69
EPS next Y
122.89
EPS next Q
-
EPS this Y
-22.45%
EPS next Y
493.84%
EPS next 5Y
591.5%
EPS last 5Y
29.77%
Revenue last 5Y
12.7%
Revenue Q/Q
-3.43%
EPS Q/Q
-25.04%
-
-
-
-
SMA20
-7%
SMA50
-8.3%
SMA100
-13.75%
Inst Own
-
Inst Trans
-
ROA
7%
ROE
9%
ROC
0.11%
Gross Margin
64%
Oper. Margin
12%
Profit Margin
9%
Payout
-
Shs Outstand
253.7M
Shs Float
130.4M
-
-
-
-
Target Price
-
52W Range
767.5-1095.0
52W High
-28.51%
52W Low
+2.07%
RSI
33
Rel Volume
0.25
Avg Volume
290.95K
Volume
73.71K
Perf Week
-1.44%
Perf Month
-9.04%
Perf Quarter
-12.59%
Perf Half Y
-8.81%
-
-
-
-
Beta
0.151742
-
-
Volatility
3.67%, 30%
Prev Close
0.38%
Price
782.85
Change
-0.29%

IPCALAB.NS Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-03-31

Metric History 2018-03-312019-03-312020-03-312021-03-31 2022-03-31
Revenue per share
127.04146.14180.4210.87230.17
Net income per share
9.4917.6123.9945.0134.91
Operating cash flow per share
13.5219.4822.3343.0433.8
Free cash flow per share
8.112.3410.2128.7714.89
Cash per share
8.6614.7116.5429.9158.89
Book value per share
106.52123.58143.55185.63216.83
Tangible book value per share
101.35115.33136.22179.86211.13
Share holders equity per share
106.52123.58143.55185.63216.83
Interest debt per share
25.7919.1320.4410.8232.17
Market cap
83.93B122.88B175.91B241.09B269.93B
Enterprise value
88.71B124.72B180.34B242.08B275.25B
P/E ratio
35.0627.6229.0121.1530.53
Price to sales ratio
2.623.333.864.514.63
POCF ratio
24.624.9631.1822.1231.53
PFCF ratio
41.0639.4268.1933.0971.58
P/B Ratio
3.123.944.855.134.92
PTB ratio
3.123.944.855.134.92
EV to sales
2.773.383.964.534.72
Enterprise value over EBITDA
18.0416.6318.6315.1520.4
EV to operating cash flow
26.0125.3431.9622.2132.15
EV to free cash flow
43.440.0169.933.2372.99
Earnings yield
0.030.040.030.050.03
Free cash flow yield
0.020.030.010.030.01
Debt to equity
0.530.450.450.290.38
Debt to assets
0.350.310.310.220.27
Net debt to EBITDA
0.970.250.460.060.39
Current ratio
1.932.172.153.033.04
Interest coverage
12.129.2447.01153.37140.03
Income quality
1.421.110.930.960.97
Dividend Yield
000.0100
Payout ratio
0.060.030.20.090.11
Sales general and administrative to revenue
0.020.020.010.020
Research and developement to revenue
0.010.010.010.010
Intangibles to total assets
0.030.050.040.030.03
Capex to operating cash flow
-0.4-0.37-0.54-0.33-0.56
Capex to revenue
-0.04-0.05-0.07-0.07-0.08
Capex to depreciation
-0.77-0.99-1.46-1.73-2.06
Stock based compensation to revenue
00000
Graham number
150.78221.26278.38433.58412.67
ROIC
0.070.120.130.220.13
Return on tangible assets
0.060.10.120.190.12
Graham Net
-30.5-19.99-21.348.0113.84
Working capital
9.38B12.8B15.29B23.04B29.91B
Tangible asset value
25.58B29.14B34.42B45.55B53.48B
Net current asset value
5.17B9.65B12.37B20.85B23.87B
Invested capital
0.230.150.140.060.15
Average receivables
00000
Average payables
4.41B4.74B5.67B6.38B6.12B
Average inventory
8.81B9.77B11.98B14.59B17.26B
Days sales outstanding
00000
Days payables outstanding
131.41148.31130.26134.95101.03
Days of inventory on hand
273.26303.37282.61323.08336.58
Receivables turnover
00000
Payables turnover
2.782.462.82.73.61
Inventory turnover
1.341.21.291.131.08
ROE
0.090.140.170.240.16
Capex per share
-5.42-7.15-12.12-14.27-18.91

Quarterly Fundamentals Overview

Last date of statement is 2022-12-31 for Q3

Metric History 2021-12-312022-03-312022-06-302022-09-30 2022-12-31
Revenue per share
56.3850.8162.5263.0860.93
Net income per share
7.765.135.645.674.25
Operating cash flow per share
00000
Free cash flow per share
00000
Cash per share
058.79057.410
Book value per share
0216.470227.670
Tangible book value per share
0210.780221.920
Share holders equity per share
0216.470227.670
Interest debt per share
031.95029.280
Market cap
274.86B270.39B227.65B232.22B213.93B
Enterprise value
0275.71B0235.69B0
P/E ratio
34.8951.9139.7840.3449.59
Price to sales ratio
19.2120.9714.3614.5113.84
POCF ratio
00000
PFCF ratio
00000
P/B Ratio
04.9204.020
PTB ratio
04.9204.020
EV to sales
021.39014.720
Enterprise value over EBITDA
0123.46080.180
EV to operating cash flow
00000
EV to free cash flow
00000
Earnings yield
0.0100.010.010.01
Free cash flow yield
00000
Debt to equity
00.3800.350
Debt to assets
00.2700.260
Net debt to EBITDA
02.3801.180
Current ratio
03.0403.290
Interest coverage
174.2446.8629.921.1513.77
Income quality
00000
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
00.0300.030
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
0158.120170.420
ROIC
00.0200.020
Return on tangible assets
00.0200.020
Graham Net
013.82012.990
Working capital
029.91B031.7B0
Tangible asset value
053.48B056.32B0
Net current asset value
023.87B025.15B0
Invested capital
00.1500.130
Average receivables
00000
Average payables
00000
Average inventory
00000
Days sales outstanding
00000
Days payables outstanding
0117.77090.250
Days of inventory on hand
0392.340285.490
Receivables turnover
00000
Payables turnover
00.76010
Inventory turnover
00.2300.320
ROE
00.0200.020
Capex per share
00000

IPCALAB.NS Frequently Asked Questions

What is Ipca Laboratories Limited stock symbol ?

Ipca Laboratories Limited is a IN stock and trading under the symbol IPCALAB.NS

What is Ipca Laboratories Limited stock quote today ?

Ipca Laboratories Limited stock price is $782.85 today.

Is Ipca Laboratories Limited stock public?

Yes, Ipca Laboratories Limited is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap